Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: CYTOKIND INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2022-09-19 to 2024-06-30
Current total value of award: $749000
Description: CYTOKIND: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO PROVIDE CLINICAL VALIDATION FOR THE TREATMENT OF COVID WITH NB-UVB THERAPY. A SUBMISSION TO THE FDA FOR A NEW INDICATION WILL BE MADE.